Abiopharma

Clinical trial NCT05253651 updates: 1. completion date: 2029-07-27 → 2030-07-03 2. primary completion date: 2026-04-03 → 2027-12-31

Clinical trial NCT07218900 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07184619 updates: 1. completion date: 2026-09-01 → 2026-12-31 2. primary completion date: 2026-09-01 → 2026-12-31

Clinical trial NCT05870579: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06213974 updates: 1. completion date: 2026-09-01 → 2026-07-31 2. primary completion date: 2026-06-01 → 2026-07-31

Clinical trial NCT04189614 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-05-01 → 2026-05-07 3. primary completion date: 2026-05-01 → 2026-05-07

Clinical trial NCT05878951 updates: 1. completion date: 2026-08-24 → 2026-12-31 2. primary completion date: 2026-06-01 → 2026-09-01

Clinical trial NCT06052631: start date: 2026-06-08 → 2026-06-09.

Clinical trial NCT05516537 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-01 → 2026-01-30 3. primary completion date: 2025-12-01 → 2025-12-31 4. enrollment: 100 → 121 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04722835 updates: 1. status: UNKNOWN → RECRUITING 2. completion date: 2022-12-31 → 2030-12-31 3. primary completion date: 2022-12-31 → 2030-12-31